PREVALENCE AND MANAGEMENT OF URINARY TRACT INFECTIONS IN TYPE 2 DIABETIC PATIENTS
NAJLAA MOHAMMAD ALSUDAIRY *
National Guard Hospital, King Abdulaziz Medical City, SCOHS, Jeddah, Saudi Arabia.
ELAF ABDULRAHEEM ABDULRAHMAN ALGHURAIBI
Baish General Hospital, Jazan, KSA.
KHOWLA MOHAMMED R. ALGETHAMI
King Saud Bin Abdul-Aziz University for Health Science, KSA.
ABDULRAHMAN AHMED M. ASIRI
GP, Mahyal Assir General Hospital, Mahyal Assir, Saudi Arabia.
ABDULLAH SULAIMAN ALQEFARI
Ministry of Health, KSA.
HASSAN SALEM HASSAN ALSHARYAH
Ministry of Health, KSA.
MOHAMMED AHMED HUMEYED
King Khaled University, KSA.
DINA GHURMULLAH M. ALZAHRANI
Hawtat Sudair General Hospital, KSA.
ZAINAB ABDULJALIL ALMANSUOR
King Faisal University, KSA.
AHMED SALMAN ALMEGDAD
MCH-DAMMAM, KSA.
ALMISBAH, MAHDI HASSAN A.
Prince Sultan Mulijah Hospital, KSA.
SHURUQ ABDULLAH S. ALBALAWI
MCH-Tabuk, KSA.
MUSTAFA YAHYA HUSSAIN NAJMI
Samtah General Hospital, KSA.
ABDULJALIL ALMARZOOQ
King Fahad Hospital Hufof-Alhasa, KSA.
KAWTHAR FAWAZ ALHAMWAN
Algharbei Primary Health Care Center, AlQurayyat, KSA.
*Author to whom correspondence should be addressed.
Abstract
Diabetes mellitus (DM) is a polygenic illness that affects many other organs. In people with type 2 diabetes, urinary tract infection is the most prevalent, the most severe, and has the worst consequences. They are also more frequently caused by microorganisms that are resistant to antibiotics. Immune system dysfunction, poor metabolic regulation, and inadequate bladder emptying owing to autonomic neuropathy may all contribute to these individuals' increased risk of urinary tract infections. The novel anti-diabetic sodium glucose cotransporter 2 inhibitors were not shown to raise the likelihood of symptomatic urinary tract infections appreciably. Urinary tract infection symptoms are comparable to those seen in people without diabetes, while some patients with diabetic neuropathy may exhibit changed clinical findings. The existence of symptoms, the severity of systemic symptoms, whether the infection is limited in the bladder or also includes the kidney, the presence of urologic abnormalities, concomitant metabolic disturbances, and renal function all influence treatment. There is no evidence that diabetic people with asymptomatic bacteriuria should be treated. Diabetes length, age, gender, method of drug administration, kind of medicines used in diabetes, poor glycemic control, obesity, unsanitary settings, sexual intercourse, and type of DM are all risk factors for UTI in diabetic patients. Antibiotic usage on a daily basis has rendered numerous harmful microorganisms resistant to their effects. In the long run, if UTI in diabetes people is not treated, it might lead to serious problems. Furthermore, the pattern of antibiotic resistance varies by geographical area. As a result, the use of susceptible antibiotics to treat UTI in diabetes patients has become critical. Medline and PubMed public database searches was carried out for papers written all over the world on UTI in diabetic patients. No predictive analytics technology was used. To evaluate the initial results and the methods of conducting the paper, the group members reviewed the data.
Keywords: Diabetes mellitus, urinary tract infection, antibiotics, management, prevalence, diabetic patients